MDGLMadrigal Pharmaceuticals, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 18419
Ticker: MDGL
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2007-02-06
Round lot: 40
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: MDGL

Detail

Enriched 2026-08-14 20:47

Market cap: $12,388,432,361.2
Shares outstanding (class): 23,104,126
Shares outstanding (weighted): 23,104,126
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 915
Location: WEST CONSHOHOCKEN, PA
Homepage: https://www.madrigalpharma.com
Description: Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.

Market cap and share counts drift.

Funds holding this security

205 funds · 211 positions · $2.63B reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$306.92M	0.02%	586,327 NS	FIGI
Janus Henderson Forty Fund JANUS INVESTMENT FUND	—	$224.79M	1.09%	429,415 NS	FIGI
VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS	VB	$221.50M	0.13%	423,146 NS	FIGI
iShares Russell 2000 ETF iShares Trust	IWM	$218.80M	0.30%	417,988 NS	FIGI
VANGUARD SMALL-CAP GROWTH INDEX FUND VANGUARD INDEX FUNDS	VBK	$123.87M	0.32%	236,629 NS	FIGI
Janus Henderson Enterprise Fund JANUS INVESTMENT FUND	—	$122.11M	0.60%	233,269 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$108.84M	0.13%	207,926 NS	FIGI
State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST	XBI	$102.81M	1.38%	196,408 NS	FIGI
Janus Henderson Contrarian Fund JANUS INVESTMENT FUND	—	$98.58M	2.30%	188,314 NS	FIGI
iShares Biotechnology ETF iShares Trust	IBB	$81.32M	1.00%	155,341 NS	FIGI
Janus Henderson Global Life Sciences Fund JANUS INVESTMENT FUND	—	$78.10M	1.50%	149,195 NS	FIGI
iShares Russell 2000 Growth ETF iShares Trust	IWO	$73.02M	0.60%	139,492 NS	FIGI
Hood River Small-Cap Growth Fund Manager Directed Portfolios	—	$70.52M	1.36%	134,720 NS	FIGI
Janus Henderson Triton Fund JANUS INVESTMENT FUND	—	$42.04M	0.81%	80,301 NS	FIGI
T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC.	—	$39.12M	0.36%	74,723 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERMDGL
FIGI_COMPOSITEBBG000QS6NV8
FIGI_SHARE_CLASSBBG001SNKQ42
CIK0001157601
ISINUS5588681057
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Madrigal Pharmaceuticals is a biopharmaceutical company focused on developing treatments for liver diseases, classified under pharmaceutical preparations.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.